Patricia Troncoso

发表

The Prostatic Capsule: Does It Exist? Its Importance in the Staging and Treatment of Prostatic Carcinoma

David J. Grignon, D. Grignon, P. Troncoso, 1989, The American journal of surgical pathology.

Steps toward mapping the human vasculature by phage display

Kim-Anh Do, Raphael E. Pollock, Keith A. Baggerly, 2002, Nature Medicine.

Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy.

Koji Okihara, Funda Vakar-Lopez, P. Troncoso, 2002, Urology.

Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues

John F. Ward, Christopher Logothetis, Jingjing Sun, 2009, Proceedings of the National Academy of Sciences.

Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study

Lee T. Sam, Robert J. Lonigro, Arul M. Chinnaiyan, 2011, Science Translational Medicine.

Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

Clement Adebamowo, Ritika Kundra, Steven J. M. Jones, 2018, Cell reports.

Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer

Kim-Anh Do, Kevin Coombes, Shawn Brisbay, 2008, BMC Medical Genomics.

Fingerprinting the circulating repertoire of antibodies from cancer patients

Kim-Anh Do, Christopher J. Logothetis, Massimo Cristofanilli, 2003, Nature Biotechnology.

Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients

Emmanuel Dias-Neto, Jeffrey E Gershenwald, Wadih Arap, 2011, Proceedings of the National Academy of Sciences.

Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: a modular phase I trial in androgen-independent prostate cancer.

Peter F Thall, Paul Mathew, Christopher Logothetis, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer

Wenjun Chang, Likun Li, Spyridon Basourakos, 2017, Science Signaling.

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder

Lawrence D. True, Michael J. Becich, Isabell A. Sesterhenn, 1998 .

Micropapillary Variant of Transitional Cell Carcinoma of the Urinary Bladder Histologic Pattern Resembling Ovarian Papillary Serous Carcinoma

Mahul B. Amin, P. Troncoso, M. Amin, 1994, The American journal of surgical pathology.

Natural history of biochemical progression after radical prostatectomy based on length of a positive margin.

P. Troncoso, R. Babaian, A. Ochiai, 2008, Urology.

Model Systems of Prostate Cancer: Uses and Limitations

Christopher J. Logothetis, Andrew C. von Eschenbach, P. Troncoso, 1998, Cancer and Metastasis Reviews.